Last updated: May 26, 2026
Nexium 24HR is a branded OTC proton pump inhibitor containing esomeprazole magnesium. The supplier and manufacturing footprint depends on (1) whether the reference is the active pharmaceutical ingredient (API) or finished dosage form, and (2) whether the product is the delayed-release capsule sold OTC or any related branded prescription footprint. Public data typically identifies the marketing authorization holder (brand owner), contract manufacturers that build finished product, and logistics/packaging vendors listed on labels, while API sourcing is less consistently disclosed.
Who supplies Nexium 24HR (esomeprazole magnesium) capsules?
Quick answer: The branded product is supplied through the brand owner’s commercial supply chain, using contract manufacturing for finished dosage forms and external sourcing for API. Final packaging and labeling are typically performed under the brand owner’s quality system, often by contract packagers.
What does “supplier” mean for Nexium 24HR?
For business and litigation risk, “supplier” usually breaks into four layers:
- API supplier (esomeprazole magnesium)
- Finished dosage form manufacturer (delayed-release capsule filling + coating)
- Packager (bottling or blistering, labeling, and cartonization)
- Importer/distributor for certain channels and geographies
Where to find supplier identity (label-facing sources)
For Nexium 24HR sold in the US:
- Outer carton and bottle labeling typically show the company responsible for distribution and sometimes a manufacturing/packaging site.
- FDA drug listing and inspection records identify manufacturing facilities used under the marketing application’s supply chain.
- Establishment inspection reports and Drug Establishment Registration and Listing (DRLM) records indicate facility identities for manufacturing and packaging.
What companies manufacture Nexium 24HR finished dosage form (delayed-release capsules)?
Quick answer: Nexium 24HR is manufactured by one or more registered contract manufacturers and packed by one or more registered packagers under the brand owner’s application.
Typical manufacturing steps relevant to supplier mapping
- API blending with excipients for delayed-release pellets/tablets-in-capsule formulation
- Encapsulation and delayed-release coating process control
- Lot release testing under cGMP
- Bottling/blister packing and packaging line labeling
How many manufacturers are used?
Branded OTC supply chains usually use multiple manufacturing sites over time due to capacity planning, change control, and regulatory submissions. Supplier lists can change by lot and by revision to the FDA facility listing.
Who supplies esomeprazole magnesium API used in Nexium 24HR?
Quick answer: API is sourced from registered API manufacturers and/or global chemical suppliers that supply esomeprazole magnesium under cGMP and are supported by regulatory documentation.
Why API sourcing is harder to pin down from consumer-facing labels
- API suppliers often do not appear on OTC bottle labels.
- Brand owners may procure API through intermediaries or global trading platforms.
- API changeovers are common even within the same product form.
What to target when mapping API suppliers
- Facilities registered for API manufacture tied to the application’s regulatory history
- Establishment identifiers that correspond to “Active Ingredient Manufacturing” and “Finished Dosage Form Manufacturing”
- Site-level inspection footprints (covered under FDA surveillance)
How do Nexium 24HR supplier roles differ from Nexium prescription (esomeprazole) supply?
Quick answer: Supplier networks can overlap but are not guaranteed to be identical because OTC and prescription dosage forms can differ in strength, packaging, and sometimes formulation or process parameters.
Key comparative mapping points
- OTC “24HR” products often map to specific capsule strengths and packaging formats
- Prescription esomeprazole products can include additional manufacturing or packaging variants
- Regulatory filings may cite different manufacturing sites even with the same active ingredient
What is the FDA regulatory status of Nexium 24HR and how does it affect supplier identification?
Quick answer: Nexium 24HR is approved for OTC use under an NDA-associated branded product listing; supplier identity is anchored to the FDA listing of manufacturing/packaging facilities associated with the approved product.
Orange Book versus OTC mapping
- The Orange Book is relevant for prescription products and approved formulations where patent listings exist.
- OTC products often still have manufacturing facility footprints in FDA systems, but patent listings are not always the primary entry point for “supplier” mapping.
Facilities to monitor for supplier changes
- API manufacturing facilities
- Sterile-related processes (not applicable here)
- Solid oral dosage form manufacturing sites
- Primary packaging and labeling facilities
What patent and exclusivity angle matters for suppliers of Nexium 24HR?
Quick answer: Supplier switching risk is more operational than patent-led for branded OTC once key formulation and method-of-use patents have expired. The more relevant constraints are regulatory approval history and facility qualification, not remaining exclusivity on the capsule.
Why suppliers still matter even after patent expiration
Even with patent expiry, brand owners protect:
- Process know-how and specifications
- Controlled formulation and coating parameters
- Supplier quality systems and stability data packages
- Brand packaging and distribution lanes
Which supplier types are most likely to change over time for Nexium 24HR?
Quick answer: Contract manufacturing and packaging sites are the most likely to change via FDA supplements and facility updates.
Common change drivers
- capacity expansions and cost optimization
- facility remediation or compliance events
- geographic diversification of supply chain
- regulatory filing updates to add or remove manufacturing lines
What generic entry risks exist for Nexium 24HR that affect supplier strategy?
Quick answer: Esomeprazole 24-hour delayed-release products face competitive generic and AB-rated risks on the same active ingredient and dosage form, so supplier strategy is often geared to maintain uninterrupted supply and defend quality and supply continuity.
Why supplier continuity matters commercially
If contract manufacturing sites shift, brand owners can face:
- transitional validation timelines
- stability data generation requirements
- label and packaging line qualification delays
Supplier mapping deliverables you can use for diligence and negotiations
Quick answer: For any transaction, licensing, or dispute diligence around Nexium 24HR, focus on facility and process mapping rather than only corporate names.
Diligence checklist
- Identify registered manufacturing and packaging establishments tied to the marketed product
- Track which sites are used for each pack size and strength
- Build a timeline of facility additions/removals using FDA listing history
- Validate whether any new facility correlates to manufacturing change supplements
Key Takeaways
- “Suppliers” for Nexium 24HR include API manufacturers, finished dosage form manufacturers, and packagers, with facility identity anchored to FDA-registered manufacturing/packaging establishments.
- Finished dosage form and packaging supplier sites change more frequently than API suppliers due to capacity and compliance drivers.
- Patent/exclusivity is rarely the operational bottleneck for supplier changes post-expiry; facility qualification, regulatory filings, and quality systems are the practical constraints.
- For high-stakes decisions, supplier mapping should be built around facility registrations and manufacturing chain evidence, not just corporate branding.
FAQs
-
Is Nexium 24HR made by a single manufacturer or multiple contract sites?
Branded oral supply chains commonly use multiple manufacturing and packaging facilities to manage capacity and regulatory continuity.
-
Do API suppliers for esomeprazole magnesium appear on Nexium 24HR labels?
Usually no; API sourcing is typically not shown on consumer-facing labeling.
-
How can I identify the manufacturing site for a specific Nexium 24HR bottle lot?
Use lot-specific label text and reconcile it to FDA-registered establishments associated with the product.
-
Are Nexium 24HR suppliers the same as those for prescription esomeprazole brands?
Not necessarily. Overlap can occur, but site use can differ by product configuration and regulatory history.
-
What changes trigger FDA facility updates for an OTC PPI like Nexium 24HR?
Manufacturing line transfers, added/removed facilities, process parameter changes that require comparability, and packaging line or labeling changes supported by supplements.
References
- US Food and Drug Administration (FDA). Drug Establishment Registration and Listing (DRLM) database.
- FDA. Orange Book: Approved Drug Products with Therapeutic Equivalence Evaluations.
- FDA. Drugs@FDA database for product and application information.
